2.4.1.9 Html 146 259 1 false 52 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.momentapharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.momentapharma.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.momentapharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.momentapharma.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS false false R5.htm 00205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Sheet http://www.momentapharma.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) false false R6.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.momentapharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 10101 - Disclosure - The Company Sheet http://www.momentapharma.com/role/DisclosureCompany The Company false false R8.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 10301 - Disclosure - Intangible Assets Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssets Intangible Assets false false R10.htm 10401 - Disclosure - Restricted Cash Sheet http://www.momentapharma.com/role/DisclosureRestrictedCash Restricted Cash false false R11.htm 10501 - Disclosure - Collaboration and License Agreements Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreements Collaboration and License Agreements false false R12.htm 10601 - Disclosure - Share-Based Payments Sheet http://www.momentapharma.com/role/DisclosureShareBasedPayments Share-Based Payments false false R13.htm 10701 - Disclosure - Tax Incentive Agreement Sheet http://www.momentapharma.com/role/DisclosureTaxIncentiveAgreement Tax Incentive Agreement false false R14.htm 10801 - Disclosure - At-The-Market Offering Sheet http://www.momentapharma.com/role/DisclosureAtMarketOffering At-The-Market Offering false false R15.htm 10901 - Disclosure - Commitments and Contingencies Sheet http://www.momentapharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R16.htm 11001 - Disclosure - Subsequent Event Sheet http://www.momentapharma.com/role/DisclosureSubsequentEvent Subsequent Event false false R17.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R18.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R19.htm 30303 - Disclosure - Intangible Assets (Tables) Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) false false R20.htm 30503 - Disclosure - Collaboration and License Agreements (Tables) Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreementsTables Collaboration and License Agreements (Tables) false false R21.htm 30603 - Disclosure - Share-Based Payments (Tables) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsTables Share-Based Payments (Tables) false false R22.htm 30903 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.momentapharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R23.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R24.htm 40202 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R25.htm 40203 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) false false R26.htm 40204 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) false false R27.htm 40205 - Disclosure - Summary of Significant Accounting Policies (Details 5) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails5 Summary of Significant Accounting Policies (Details 5) false false R28.htm 40301 - Disclosure - Intangible Assets (Details) Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) false false R29.htm 40401 - Disclosure - Restricted Cash (Details) Sheet http://www.momentapharma.com/role/DisclosureRestrictedCashDetails Restricted Cash (Details) false false R30.htm 40501 - Disclosure - Collaboration and License Agreements (Details) Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreementsDetails Collaboration and License Agreements (Details) false false R31.htm 40601 - Disclosure - Share-Based Payments (Details) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsDetails Share-Based Payments (Details) false false R32.htm 40602 - Disclosure - Share-Based Payments (Details 2) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsDetails2 Share-Based Payments (Details 2) false false R33.htm 40701 - Disclosure - Tax Incentive Agreement (Details) Sheet http://www.momentapharma.com/role/DisclosureTaxIncentiveAgreementDetails Tax Incentive Agreement (Details) false false R34.htm 40801 - Disclosure - At-The-Market Offering (Details) Sheet http://www.momentapharma.com/role/DisclosureAtMarketOfferingDetails At-The-Market Offering (Details) false false R35.htm 40901 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.momentapharma.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R36.htm 41001 - Disclosure - Subsequent Event (Details) Sheet http://www.momentapharma.com/role/DisclosureSubsequentEventDetails Subsequent Event (Details) false false All Reports Book All Reports Element mnta_CollaborativeArrangementPercentageOfProfitSharing had a mix of decimals attribute values: 0 2. Element us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount had a mix of decimals attribute values: -3 0. Element us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears had a mix of decimals attribute values: -5 -3. Element us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears had a mix of decimals attribute values: -5 -3. Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -6 -5 -3. Element us-gaap_RestrictedCashAndCashEquivalentsNoncurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage had a mix of decimals attribute values: 2 4. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod had a mix of decimals attribute values: -3 0. Columns in Cash Flows statement 'CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 109 days and at least 24 values. Shorter duration columns must have at least one fourth (6) as many values. Column '4/1/2015 - 4/30/2015' is shorter (29 days) and has only 2 values, so it is being removed. 'Monetary' elements on report '40301 - Disclosure - Intangible Assets (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40501 - Disclosure - Collaboration and License Agreements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40801 - Disclosure - At-The-Market Offering (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40901 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41001 - Disclosure - Subsequent Event (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Process Flow-Through: 00205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Process Flow-Through: 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '3 Months Ended Apr. 20, 2015' mnta-20150331.xml mnta-20150331.xsd mnta-20150331_cal.xml mnta-20150331_def.xml mnta-20150331_lab.xml mnta-20150331_pre.xml true true